MillerKD, SiegelRL, LinCC, et al.Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin, 2016; 66:271–289.
2.
OeffingerKC, MertensAC, SklarCA, et al.Chronic health conditions in adult survivors of childhood cancer. N Engl J Med, 2006; 355:1572–1582.
3.
ReulenRC, WinterDL, FrobisherC, et al.Long-term cause-specific mortality among survivors of childhood cancer. JAMA, 2010; 304:172–179.
4.
OeffingerKC, Adams-HuetB, VictorRG, et al.Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol, 2009; 27:3698–3704.
5.
NottageKA, NessKK, LiC, SrivastavaD, et al.Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia—From the St. Jude Lifetime Cohort. Br J Haematol, 2014; 165:364–374.
6.
OudinC, SimeoniM-C, SirventN, et al.Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood, 2011; 117:4442–4448.
7.
BerbisJ, MichelG, BaruchelA, et al.Cohort profile: The French childhood cancer survivor study for leukaemia (L.E.A. Cohort). Int J Epidemiol, 2015; 44:49–57.
8.
AnnaloroC, UsardiP, AiraghiL, et al.Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant, 2008; 41:797–804.
9.
MajhailNS, FlowersME, NessKK, et al.High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant, 2009; 43:49–54.
10.
OudinC, AuquierP, BertrandY, et al.Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: An L.E.A. study. Bone Marrow Transplant, 2015; 50:1438–1444.
11.
SaultierP, AuquierP, BertrandY, et al.Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: An L.E.A. study. Haematologica, 2016; 101:1603–1610.
12.
GurneyJG, NessKK, SibleySD, et al.Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer, 2006; 107:1303–1312.
13.
ParisC, YatesL, LamaP, et al.Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents. Pediatr Blood Cancer, 2012; 59:306–310.
14.
KarakurtH, SarperN, KılıçSÇ, et al.Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance. Pediatr Hematol-Oncol, 2012; 29:551–561.
15.
BlijdorpK, van WaasM, van der LelyA-J, et al.Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. Leuk Res, 2013; 37:367–371.
16.
BajwaR, SkeensM, GareeA, et al.Metabolic syndrome and endocrine dysfunctions after HSCT in children. Pediatr Transplant, 2012; 16:872–878.
17.
TrimisG, MoschoviM, PapassotiriouI, et al.Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol, 2007; 29:309–314.
18.
van WaasM, NeggersSJCMM, PietersR, et al.Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol, 2010; 21:1121–1126.
19.
ChemaitillyW, LiZ, HuangS, et al.Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: Areport from the St. Jude Lifetime Cohort study. J Clin Oncol, 2015; 33:492–500.
20.
TonorezosES, VegaGL, SklarCA, et al.Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer, 2012; 58:31–36.
21.
SmithWA, LiC, NottageKA, et al.Lifestyle and metabolic syndrome in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study: Metabolic Syndrome in Childhood Cancer. Cancer, 2014; 120:2742–2750.
22.
BulowB, LinkK, AhrenB, et al.Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Clin Endocrinol (Oxf), 2004; 61:683–691.
23.
FollinC, ThilénU, AhrénB, et al.Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab, 2006; 91:1872–1875.
